Apnimed, Inc. (APMD)
NASDAQ: APMD · Real-Time Price · USD
25.00
+9.00 (56.25%)
At close: Jul 31, 2026, 4:00 PM EDT
22.52
-2.48 (-9.92%)
After-hours: Jul 31, 2026, 7:57 PM EDT
Apnimed Employees
Apnimed had 65 employees as of March 31, 2026. The number of employees did not change since the number was last reported on December 31, 2025.
Employees
65
Change
n/a
Growth
n/a
Revenue / Employee
$1,848,462
Profits / Employee
-$489,631
Market Cap
999.99M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Mar 31, 2026 | 65 | 0 | - |
| Dec 31, 2025 | 65 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| MiMedx Group | 808 |
| Gyre Therapeutics | 625 |
| REGENXBIO | 371 |
| Allogene Therapeutics | 152 |
| MapLight Therapeutics | 133 |
| Neurogene | 131 |
| BridgeBio Oncology Therapeutics | 106 |
| AgomAb Therapeutics NV | 62 |
APMD News
- 15 hours ago - Apnimed opens at $22.00, IPO priced at $16.00 - TheFly
- 20 hours ago - Apnimed 12M share IPO priced at $16.00 - TheFly
- 4 days ago - Sleep apnea pill developer Apnimed targets $608 million valuation in US IPO - Reuters
- 21 days ago - Sleep apnea pill maker Apnimed files for US IPO as biotech market revives - Reuters
- 21 days ago - Apnimed IPO Registration Document (S-1) - SEC